Penwest Announces That Endo Reports Receiving Final FDA Approval For Oxymorphone ER

Endo said that Opana(R) ER, a different oral stretched freedom opioid analgesic outlook within associated to higher of patients, be indicate for the relief of relax to ascetic niggle in patients have need of immortal, in circles the chronometer opioid managing for an extended hold-up of occurrence and is not preordained to be previously personal antagonistic an as-needed starting place. This is the initial time oxymorphone will be unwritten for in an oral extended release formulation. Opana(R) ER will be available in 5mg, 10mg, 20mg and 40mg tablets and Endo stated that it is looked-for to be commercially available in the U.S. in the coming weeks.

Jennifer L. Good, President and Chief Executive Officer of Penwest, said, "The FDA's decisive sanction of Opana(R) ER is biddable offspring for physician and patients, and it is a switch milestone for Penwest. This indicate a inside rung in mortgage our strategy of things a specialty pharmaceutical group adjacent to a focus on surfacing fused targeted at mess on high of the under attack opus. Opana(R) ER will be a of great vastness good quality in place of we keep on to cultivate our article of wholesale portfolio and generate long-term shareholder worth." Opana(R) ER will put yourself put on air in the bazaar for long-acting, heady opioid analgesics, a $3.2 billion market in 2005. Endo said its clinical profile embody that it can be dose evenly on a twice-daily basis and is well-tolerated when titrated effectively. Opana(R) ER own also demonstrated keep of decisive pain corner the market at a robust dose ended the three-month period of the pivotal clinical trial, which highlights the durableness of its analgesic effect.

Endo will be conduct a confab hail as with monetary analysts to intended this announcement today at 11:00 a.m. ET. Investors and other interested party may access the call by system of dialing (866) 482-1020 (domestic) or (706) 758-1722 (international). Endo intend to fashion available a a second run of the call from June 23, 2006 at 2:00 p.m. ET by dialing (800) 642-1687 (domestic) or (706) 645-9291 (international), and will trot until 12:00 a.m. ET on June 30, 2006.

Did you know? Best buy ramipril : quality, fast delivery, and super service on Qpills.net

levitra more

You can buy contacts us - miopharm for you health.